Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Ph. D., Doctor en Medicina y Cirugía, Universitat Autònoma de Barcelona (UAB)
Award Date: 23 Jan 1991
Degree, Llicenciat, Universitat Autònoma de Barcelona (UAB)
Award Date: 1 Jan 1984
Fingerprint
Dive into the research topics where Luis Puig-Sanz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Brodalumab Versus Guselkumab in Patients with Moderate-to-Severe Psoriasis with an Inadequate Response to Ustekinumab : A Randomized, Multicenter, Double-Blind Phase 4 Trial (COBRA)
Reich, K., Bianchi, L., Khemis, A., Maul, J.-T., Tsianakas, A., Schempp, C. M., Petersen, K., Noergaard, M. M. & Puig Sanz, L., 1 Feb 2024, In: Dermatology and Therapy. 14, 2, p. 453-468 16 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis
Rusiñol, L. & Puig Sanz, L., 15 Jan 2024, In: International Journal of Molecular Sciences. 25, 2, 1042.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
New and Emerging Oral/Topical Small-Molecule Treatments for Psoriasis
Carmona Rocha, E., Rusiñol, L. & Puig Sanz, L., 6 Feb 2024, In: Pharmaceutics. 16, 2, 239.Research output: Contribution to journal › Article › Research › peer-review
Open Access6 Citations (Scopus) -
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors : A Retrospective, Multinational, Multicentre Study
Torres, T., Chiricozzi, A., Puig Sanz, L., Lé, A. M., Marzano, A. V., Dapavo, P., Dauden, E., Carrascosa, J. M., Lazaridou, E., Duarte, G., Carvalho, A. V. E., Romiti, R., Rompoti, N., Teixeira, L., Abreu, M., Ippoliti, E., Maronese, C. A., Llamas-Velasco, M., Vilarrasa-Rull, E. & del Alcázar, E. & 5 others, , 24 Jan 2024, In: American Journal of Clinical Dermatology. 25, 2, p. 333-342 10 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access9 Citations (Scopus) -
A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
Kirkham, B. W., Egeberg, A., Behrens, F., Pinter, A., Merola, J. F., Holzkämper, T., Gallo, G., Ng, K. J., Bolce, R., Schuster, C., Nash, P. & Puig Sanz, L., 2023, In: Rheumatology and Therapy. 10, p. 1127-1146 20 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus)
Thesis
-
Modulación farmacológica y dietética del metabolismo del ácido araquidónico. Implicaciones en la psoriasis
Puig Sanz, L. (Author), de Moragas, J. M. (Director), 21 Jan 1991Student thesis: Doctoral thesis
Datasets
-
Urine metabolome profiling of immune-mediated inflammatory diseases
Julià, A. (Creator), Vinaixa, M. (Creator), Domènech, E. (Creator), Fernández-Nebro, A. (Creator), Cañete, J. D. (Creator), Ferrándiz, C. (Creator), Tornero, J. (Creator), Gisbert, J. P. (Creator), Nos, P. (Creator), Casbas, A. G. (Creator), Puig, L. (Contributor), González-Álvaro, I. (Creator), Pinto-Tasende, J. A. (Creator), Blanco, R. (Creator), Rodríguez, M. A. (Creator), Beltran, A. (Creator), Correig, X. (Creator), Marsal, S. (Creator) & Alonso, A. (Contributor), figshare, 9 Aug 2016
DOI: 10.6084/m9.figshare.c.3643964, https://figshare.com/collections/Urine_metabolome_profiling_of_immune-mediated_inflammatory_diseases/3643964
Dataset
-
Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey
Lebwohl, M. (Creator), Langley, R. G. (Creator), Paul, C. (Creator), Puíg, L. (Contributor), Reich, K. (Creator), van de Kerkhof, P. (Contributor), Wu, H.-L. (Creator), Richter, S. (Creator), Jardon, S. (Creator) & Gisondi, P. (Creator), Adis Journals, 6 Dec 2021
DOI: 10.6084/m9.figshare.17104586, https://adisjournals.figshare.com/articles/media/Evolution_of_Patient_Perceptions_of_Psoriatic_Disease_Results_from_the_Understanding_Psoriatic_Disease_Leveraging_Insights_for_Treatment_UPLIFT_Survey/17104586
Dataset
-
Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey
Lebwohl, M. (Creator), Langley, R. G. (Creator), Paul, C. (Creator), Puíg, L. (Contributor), Reich, K. (Creator), van de Kerkhof, P. (Contributor), Wu, H.-L. (Creator), Richter, S. (Creator), Jardon, S. (Creator) & Gisondi, P. (Creator), Adis Journals, 6 Dec 2021
DOI: 10.6084/m9.figshare.17104586.v2, https://adisjournals.figshare.com/articles/media/Evolution_of_Patient_Perceptions_of_Psoriatic_Disease_Results_from_the_Understanding_Psoriatic_Disease_Leveraging_Insights_for_Treatment_UPLIFT_Survey/17104586/2
Dataset
-
Deterioration of Health-Related Quality of Life After Withdrawal of Risankizumab Treatment in Patients with Moderate to Severe Plaque Psoriasis: A Machine Learning Predictive Model
Papp, K. A. (Creator), Soliman, A. M. (Creator), Done, N. (Creator), Carley, C. (Creator), Lemus Wirtz, E. (Contributor) & Puig, L. (Creator), Adis Journals, 18 May 2021
DOI: 10.6084/m9.figshare.14541864, https://adisjournals.figshare.com/articles/media/Deterioration_of_Health-Related_Quality_of_Life_After_Withdrawal_of_Risankizumab_Treatment_in_Patients_with_Moderate_to_Severe_Plaque_Psoriasis_A_Machine_Learning_Predictive_Model/14541864
Dataset
-
Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-To-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure
Armstrong, A. (Creator), Paul, C. (Contributor), Puig, L. (Creator), Boehncke, W. H. (Contributor), Freeman, M. (Creator), Torii, H. (Creator), Papp, K. (Creator), Griffiths, C. E. M. (Creator), Blauvelt, A. (Creator), Reich, K. (Creator), Gooderham, M. (Creator), Terui, T. (Creator), Renda, L. (Creator), Agada, N. (Creator), Xu, W. (Creator), Gallo, G. (Creator) & Lebwohl, M. G. (Creator), Adis Journals, 13 Nov 2019
DOI: 10.6084/m9.figshare.10067021, https://adisjournals.figshare.com/articles/Safety_of_Ixekizumab_Treatment_for_up_to_5_Years_in_Adult_Patients_with_Moderate-To-Severe_Psoriasis_Results_from_Greater_Than_17_000_Patient-Years_of_Exposure/10067021
Dataset